Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

DeVry Inc. (DV), ITT Educational Services, Inc. (ESI), Apollo Group Inc (APOL): The Mass Exodus From For-Profit Education

Page 1 of 2

Being a former middle school teacher and son of a university professor, I became very interested in researching for-profit education when I became a full-time Fool in the spring of 2011. After spending time investigating the industry, I was convinced that an enormous percentage of big players were reckless at best, and scam artists at worst.

I encouraged readers to stay as far away from for-profit educators as they could — though I was willing to admit there were some quality players in the industry. Since that article first appeared, the S&P 500 has returned about 34% including dividends.

Looking at six of the biggest players in the industry —  (NYSE:DV), American PublicITT Educational Services, Inc. (NYSE:ESI)Apollo Group Inc (NASDAQ:APOL)Corinthian Colleges Inc (NASDAQ:COCO), and Bridgepoint Education Inc (NYSE:BPI) — you can see that shareholders in these companies haven’t fared nearly as well.

DV Total Return Price Chart

DV Total Return Price data by YCharts.

The average company in this cohort has lost 40% of its value, meaning that it has underperformed the market by a whopping 74 percentage points!

Over the coming days, I’ll be investigating why the industry has had such a tough time. Today, I’m going to focus on one of the most important metrics investors in for-profit education should keep an eye on.

New student enrollment

While looking at the total enrollment at a school is an important data point, I would argue that new student enrollment is the most prescient. It offers investors a look into the future of the school, and whether or not it is attracting enough new students to maintain its enrollment for the coming years.

Because each school reports its earnings at a different time, and has differing ways of segmenting the year, I took the most recent statement for each company of how many new students were enrolled, and compared it to the same time period from 2010. The results show that, on average, this cohort has about a quarter fewer new students enrolling than it did three years ago.

Source: SEC filings.

I’m not surprised that American Public was the sole school to add to its enrollment, as I singled it out as far and away the best player in the industry.

DeVry Inc. (NYSE:DV), ITT Educational Services, Inc. (NYSE:ESI), and Corinthian Colleges Inc (NASDAQ:COCO) have shown middling losses, while Bridgepoint Education Inc (NYSE:BPI) and Apollo Group Inc (NASDAQ:APOL) have had dramatic drop-offs. Bridgepoint, most notably, was in danger of losing its certification over these three years, while Apollo Group Inc (NASDAQ:APOL) — parent company of the University of Phoenix — has seen its students leave in droves.

A perfect storm of trouble

In my opinion, there are three critical variables that converged to drive new student enrollment down so much at these schools.

The first was the fact that a Government Accountability Office investigation revealed appalling tactics that recruiters were using to get students to sign up. These tactics included lying on financial aid sheets in order to secure government funding. As a result, the Obama administration said recruiters’ salaries could no longer be derived from how many students signed up, causing a severe drop in new student enrollment.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!